Phức hợp vimentin/cardiolipin như một mục tiêu kháng nguyên mới của hội chứng kháng phospholipid

Hughes, 1985, The anticardiolipin syndrome., Clin Exp Rheumatol, 3, 285 Hughes, 1986, The anticardiolipin syndrome., J Rheumatol, 13, 486 Wilson, 1999, International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome., Arthritis Rheum, 42, 1309, 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)., J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Tincani, 1998, Anticardiolipin and anti-beta2 glycoprotein immunoassays in the diagnosis of antiphospholipid syndrome., Clin Exp Rheumatol, 16, 396 Bertolaccini, 2005, Antiphospholipid antibody tests: spreading the net., Ann Rheum Dis, 64, 1639, 10.1136/ard.2005.035824 Galli, 1993, Antiphospholipid antibodies: involvement of protein cofactors., Haematology, 78, 1 Bas de Laat, 2004, β2-glycoprotein I, the playmaker of the antiphospholipid syndrome., Clin Immunol, 112, 161, 10.1016/j.clim.2004.02.012 Sorice, 1994, Protein S antibodies in acquired protein S deficiencies., Blood, 83, 2383, 10.1182/blood.V83.8.2383b.2383b Sorice, 1996, Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency., Thromb Haemost, 75, 555, 10.1055/s-0038-1650320 Oosting, 1993, Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?, Blood, 81, 2618, 10.1182/blood.V81.10.2618.2618 Arvieux, 1995, Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants., Thromb Haemost, 74, 1120, 10.1055/s-0038-1649891 Kaburaki, 1997, Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus., Am J Hematol, 54, 209, 10.1002/(SICI)1096-8652(199703)54:3<209::AID-AJH6>3.0.CO;2-# Salle, 2008, Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome., J Clin Immunol, 28, 291, 10.1007/s10875-008-9188-1 Kobayashi, 1998, A lipid associated with the antiphospholipid syndrome regulates endosome structure and function., Nature, 392, 193, 10.1038/32440 Alessandri, 2005, Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus., Clin Exp Immunol, 140, 173, 10.1111/j.1365-2249.2005.02727.x Sorice, 1994, Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates., J Immunol Methods, 173, 49, 10.1016/0022-1759(94)90282-8 Miret, 1997, Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient ‘seronegative’ antiphospholipid syndrome?, Clin Exp Rheumatol, 15, 541 Hughes, 2003, Seronegative antiphospholipid syndrome., Ann Rheum Dis, 62, 1127, 10.1136/ard.2003.006163 Raschi, 2003, Role of the MyD88 transduction signalling pathway in endothelial activation by antiphospholipid antibodies., Blood, 101, 3495, 10.1182/blood-2002-08-2349 Meroni, 2004, Endothelial cell activation by antiphospholipid antibodies., Clin Immunol, 112, 169, 10.1016/j.clim.2004.02.015 Meroni, 2004, Innate immunity in the antiphospholipid syndrome: role of the Toll-like receptors in endothelial cell activation by antiphospholipid antibodies., Autoimm Rev, 3, 510, 10.1016/j.autrev.2004.07.007 Edgell, 1983, Permanent cell line expressing human factor VIII-related antigen established by hybridization., Proc Natl Acad Sci U S A, 80, 3734, 10.1073/pnas.80.12.3734 Folch, 1957, A simple method for the isolation and purification of total lipids from animal tissues., J Biol Chem, 226, 497, 10.1016/S0021-9258(18)64849-5 Perides, 1987, Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers., J Biol Chem, 262, 13742, 10.1016/S0021-9258(19)76489-8 Harris, 1990, The second international anti-cardiolipin standardization workshop/The Kaps Group., Am J Clin Pathol, 94, 476, 10.1093/ajcp/94.4.476 Margutti, 2007, Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis., Blood, 111, 4559, 10.1182/blood-2007-05-092825 Nourbakhsh, 2001, The NF-kappa b repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-kappa b-flanking sequence element., J Biol Chem, 276, 4501, 10.1074/jbc.M007532200 Hughes, 2008, Hughes syndrome (the antiphospholipid syndrome): ten clinical lessons., Autoimmun Rev, 7, 262, 10.1016/j.autrev.2007.11.017 Bertolaccini, 2005, Diagnosis of antiphospholipid syndrome., Nat Clin Pract Rheumatol, 1, 40, 10.1038/ncprheum0017 Shoenfeld, 2008, Autoantibody explosion in antiphospholipid syndrome., J Autoimmun, 30, 74, 10.1016/j.jaut.2007.11.011 Lazurova, 2007, Severe limb necrosis: primary thrombotic microangiopathy or ”seronegative“ catastrophic antiphospholipid syndrome? A diagnostic dilemma., Clin Rheumatol, 26, 1737, 10.1007/s10067-006-0487-8 Sanmarco, 2009, Clinical significance of antiphosphatidylethanolamine antibodies in the so-called “seronegative antiphospholipid syndrome.”, Autoimmun Rev, 9, 90, 10.1016/j.autrev.2009.03.007 Moisan, 2006, Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis., J Leukoc Biol, 79, 489, 10.1189/jlb.0405190 Boilard, 2003, Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2., Blood, 102, 2901, 10.1182/blood-2002-12-3702 Mor-Vaknin, 2003, Vimentin is secreted by activated macrophages., Nat Cell Biol, 5, 59, 10.1038/ncb898 Podor, 2002, Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface., J Biol Chem, 277, 7529, 10.1074/jbc.M109675200 Xu, 2004, The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature., Mol Cell Biol, 24, 9198, 10.1128/MCB.24.20.9198-9206.2004 Bryant, 2006, Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes., J Infect Dis, 193, 1685, 10.1086/504261 Huet, 2006, SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells., J Immunol, 176, 652, 10.4049/jimmunol.176.1.652 Thebault, 2002, Orderly pattern of development of the autoantibody response in (New Zealand White × BXSB) F1 lupus mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry., J Immunol, 169, 4046, 10.4049/jimmunol.169.7.4046 Blaschek, 1988, Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus., Ann Rheum Dis, 47, 708, 10.1136/ard.47.9.708 Mahesh, 2007, Autoantibodies to vimentin cause accelerated rejection of cardiac allografts., Am J Pathol, 170, 1415, 10.2353/ajpath.2007.060728 Leong, 2008, Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor., J Leukoc Biol, 83, 263, 10.1189/jlb.0607339 Sorice, 2007, Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts., Arthritis Rheum, 56, 2687, 10.1002/art.22802 Sorice, 2000, Cardiolipin on the surface of apoptotic cells as possible trigger for antiphospholipid antibodies., Clin Exp Immunol, 122, 277, 10.1046/j.1365-2249.2000.01353.x Sorice, 2004, Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis., Cell Death Differ, 11, 1133, 10.1038/sj.cdd.4401457